New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Personalis, Inc.
PSNL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

274M

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

274M

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

5.17USD
Shape0.46 ( 9.77%)
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-38%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

28%

Quote Panel

Shape
Updated October 29, 2024
1W 10.23 % 1M -3.90 % 3M 65.71 % 1Y 444.21 %

Key Metrics

Shape
  • Market Cap

    274.40M


  • Shares Outstanding

    53.07M


  • Share in Float

    31.59M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    5.17


  • Average Volume

    1.03M


  • Beta

    1.921


  • Range

    0.891-7.2


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.personalis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.43x

P/S Ratio

2.41x

P/B Ratio

0.1

Debt/Equity

-101.8%

Net Margin

$-1.6

EPS

How PSNL compares to sector?

P/E Ratio

Relative Strength

Shape

PSNL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$87M

Shape285%

2025-Revenue

$1.24

Shape-418%

2025-EPS

$62M

Shape-338%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Lake Street

initialise

Previous: Not converted

2024-04-30

Now: Buy

Credit Suisse

downgrade

Previous: Not converted

2023-02-06

Now: Neutral

Citigroup

downgrade

Previous: Buy

2023-02-06

Now: Neutral

Cowen & Co.

initialise

Previous: Not converted

2023-02-06

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.58
vs -0.40

Q4.22

arrow
arrow

N/A

-0.67
vs -0.45

Q1.23

arrow
arrow

N/A

-0.61
vs -0.63

Q2.23

arrow
arrow

N/A

-0.50
vs -0.60

Q3.23

arrow
arrow

N/A

-0.51
vs -0.58

Q4.23

arrow
arrow

N/A

-0.46
vs -0.67

Q1.24

arrow
arrow

N/A

-0.26
vs -0.61

Q2.24

arrow
arrow

N/A

-0.24
vs -0.50

Q3.24

arrow
arrow

N/A

-0.35
vs -0.51

Q4.24

arrow
arrow

N/A

-0.37
vs -0.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-33%

14.9M  vs 22.3M

Q4.22

arrow
arrow

-19%

16.7M  vs 20.7M

Q1.23

arrow
arrow

+24%

18.9M  vs 15.2M

Q2.23

arrow
arrow

-8%

16.7M  vs 18.2M

Q3.23

arrow
arrow

+23%

18.2M  vs 14.9M

Q4.23

arrow
arrow

+18%

19.7M  vs 16.7M

Q1.24

arrow
arrow

+4%

19.5M  vs 18.9M

Q2.24

arrow
arrow

+35%

22.6M  vs 16.7M

Q3.24

arrow
arrow

+17%

21.3M  vs 18.2M

Q4.24

arrow
arrow

-16%

16.5M  vs 19.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-11%

-0.11
vs -0.10

Q4.22

arrow
arrow

-14%

-0.14
vs -0.11

Q1.23

arrow
arrow

-15%

-0.15
vs -0.14

Q2.23

arrow
arrow

-14%

-0.14
vs -0.15

Q3.23

arrow
arrow

-19%

-0.19
vs -0.14

Q4.23

arrow
arrow

-21%

-0.21
vs -0.19

Q1.24

arrow
arrow

-11%

-0.11
vs -0.21

Q2.24

arrow
arrow

-11%

-0.11
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

78

78
vs 97

-20%

Q4.22

arrow
arrow

81

81
vs 78

4%

Q1.23

arrow
arrow

65

65
vs 81

-20%

Q2.23

arrow
arrow

67

67
vs 65

3%

Q3.23

arrow
arrow

65

65
vs 67

-3%

Q4.23

arrow
arrow

71

71
vs 65

9%

Q1.24

arrow
arrow

73

73
vs 71

3%

Q2.24

arrow
arrow

70

70
vs 73

-4%

Earnings Growth

Latest News